Page last updated: 2024-11-03

propranolol and Leukemia, Lymphocytic

propranolol has been researched along with Leukemia, Lymphocytic in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpentieri, U1
Minguell, JJ1
Gardner, FH1
Sheppard, JR1
Gormus, R1
Moldow, CF1

Other Studies

2 other studies available for propranolol and Leukemia, Lymphocytic

ArticleYear
Adenylate cyclase and guanylate cyclase activity in normal and leukemic human lymphocytes.
    Blood, 1981, Volume: 57, Issue:5

    Topics: Adenylyl Cyclases; B-Lymphocytes; Guanylate Cyclase; Humans; Isoproterenol; Leukemia, Lymphoid; Lymp

1981
Catecholamine hormone receptors are reduced on chronic lymphocytic leukaemic lymphocytes.
    Nature, 1977, Oct-20, Volume: 269, Issue:5630

    Topics: Adenylyl Cyclases; Alprenolol; Binding, Competitive; Cell Membrane; Humans; In Vitro Techniques; Iso

1977